–
Artiva Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.3
FY22:
−59.8
FY23:
−30.7
FY24:
−67.3
FY25:
−89.8
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−87.2
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−28.6
FY24:
−65.4
FY25:
−83.9
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−28.7
FY24:
−65.4
FY25:
−83.9
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.